ABC | Volume 112, Nº5, May 2019

Updated Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology – 2019 Arq Bras Cardiol. 2019; 112(5):649-705 patients aged 80 years or older with non ST elevationmyocardial infarction or unstable angina pectoris (after Eighty Study); an open-label randomised trial. Lancet. 2016;387(10023):1057-65. 175. Bader F, Atallah B, Brennan LF, Rimawi RH, Khalil ME. Heart failure in the elderly: ten peculiar management considerations. Heart Fail Rev. 2017;22(2):219-28. 176. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AS et al.; ESC Scientific Document Group. 2016. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-200. 177. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al.; American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240-327. 178. Rickenbacher P, Kaufmann BA, Maeder MT, Bernheim A, Goetschalckx K, PfisterOetal.;TIMI-CHFInvestigators.Heartfailurewithmid-rangeejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standardMedical therapy in Elderly patients with Congestive Heart Failure (TIMI-CHF). Eur J Heart Fail. 2017;19(12):1586-96. 179. Bocchi EA, Marcondes-Braga FG, Bacal F, Ferraz AS, Albuquerque D, Rodrigues Dde A et al. [Updating of the Brazilian guideline for chronic heart failure – 2012]. Arq Bras Cardiol. 2012;98(1 Suppl 1):1-33. 180. Vetrano DL, Lattanzio F, Martone AM, Landi F, Brandi V, Topinkova E et al. Treating heart failure in older and oldest old patients. Curr PharmDes. 2015;21(13):1659-64. 181. Upadhya B, Taffet GE, Cheng CP, Kitzman DW. J Heart failure with preserved ejection fraction in the elderly: scope of the problem. J Mol Cell Cardiol. 2015 Jun;83:73-87. 182. KruegerK,BotermannL,SchorrSG,Griese-MammenN,LaufsU,SchulzM. Age-relatedmedication adherence in patients with chronic heart failure: a systematic literature review. Int J Cardiol. 2015 Apr 1;184:728-35. 183. Chen YM, Li Y. Safety and efficacy of exercise training in elderly heart failure patients: a systematic review and meta-analysis. Int J Clin Pract. 2013;67(11):1192-8. 184. Chin KL, Skiba M, Tonkin A, Reid CM, Liew D, Krum H et al. The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice. Heart Fail Rev. 2016;21(6):675-97. 185. Anguita Sánchez M, Jiménez-Navarro M, Crespo M, Alonso-Pulpón L, de Teresa E, Castro-Beiras A et al.; OBELICA study researchers. Effect of a training program for primary care physicians on the optimization of beta- blocker treatment in elderly patients with heart failure. Rev Esp Cardiol. 2010;63(6):677-85. 186. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J et al.; SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215-25. 187. Rossi JS,Flaherty JD,FonarowGC,NunezE,GattisStoughW,AbrahamWT et al. Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Eur J Heart Fail. 2008;10(12):1215-23. 188. Komajda M, Hanon O, Hochadel M, Lopez-Sendon JL, Follath F, Ponikowski P et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J. 2009;30(4):478-86. 189. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR et al.; PARADIGM-HF Investigators and Committees. Angiotensin- neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993-1004. 190. Edelmann F, Musial-Bright L, Gelbrich G; CIBIS-ELD Investigators and Project Multicenter Trials in the Competence Network Heart Failure. TolerabilityandFeasibilityofBeta-BlockerTitration inHFpEFVersusHFrEF: Insights From the CIBIS-ELD Trial. JACC Heart Fail. 2016;4(2):140-9. 191. Taddei CF, Ramos LR, Moraes JC, WajngartenM, Libberman A, Santos SC et al. Multicenter study of elderly patients in outpatient clinics of cardiology and geriatric Brazilian institutions. Arq Bras Cardiol. 1997;69(5):327-33. 192. Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012;8(1):143-64. 193. MalachiasMV,PóvoaRM,NogueiraAR,SouzaD,CostaLS,MagalhãesME; Sociedade Brasileira de Cardiologia. 7a Diretriz Brasileira de hipertensão arterial. Arq Bras Cardiol. 2016;107(3 supl 3):1-83. 194. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D et al.; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887-98. 195. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159-219. 196. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force onClinical PracticeGuidelines. J AmColl Cardiol. 2018;71(19):e127-248. 197. Desai MY, Gerstenblith G. Contemporary cardiology: cardiovascular disease in the elderly. New Jersey: Humana Press; 2010. p. 247-50. 198. Harris R. Clinical geriatric cardiology. 2nd ed. Philadelphia: JB Lippincott Company; 1970. 199. Cheitlin MD. Valve disease in octogenarian. In: Wenger NK. (editor). Cardiovascular disease in the octogenarian and beyond. London: Martin Dunitz; 1999. p. 255-66. 200. SharmaS,MaronDJ,FigueiredoVM,PressmanGS,TalaveraF,SelpazukLet al. Mitral annular calcification. [Internet]. [Cited in 2017 Jan 30]. Available from: https://emedicine.medscape.com/article/1967024-overview. 201. Meneghelo ZM. Doença valvar no idoso. In: Borges JL. ed. Manual de Cardiogeriatria. São Paulo: Lemos Editorial; 2012. p. 138-41. 202. Tarasoutchi F, MonteraMW, GrinbergM, PiñeiroDJ, Sánchez CR, Bacelar AC et al; [Brazilian Guidelines for Valve Disease – SBC 2011 / I Guideline Inter-American Valve Disease – 2011 SIAC]. Arq Bras Cardiol. 2011;97(5 Suppl 1):1-67. 203. Nishimiura RA, Otto CM, BonowRO, Carabello BA, Erwin JP 3rd, Guyton RA et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on PracticeGuidelines. J AmColl Cardiol. 2014;63(22):e57-185. Erratum in: J Am Coll Cardiol. 2014;63(22):2489. 204. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrilation (updating the 2006 guideline). A report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2011;57(2):223-42. 205. MartinsRP,GalandV,ColetteE,BeharN,PavinD,LeclercqCetal.Defining nonvalvular atrial fibrillation: a quest for clarification. Am Heart J. 2016 Aug;178:161-7. 700